US Patent Number

9066928

Publication Date

6-30-2015

Abstract

The presently-disclosed subject matter includes methods for treating Alzheimer's disease in a subject. The subject can have Alzheimer's diseases, can be identified has being at risk for developing Alzheimer's disease, or both. The method can comprise administering a composition that includes a CD33 inhibitor, which may include a CD33 antibody. In some embodiments the composition can further comprise at least one additional component useful for treating Alzheimer's disease. The presently-disclosed subject matter also includes compositions and kits for treating Alzheimer's disease in a subject.

Assignees

University of Kentucky Research Foundation, Lexington, KY (US)

Application Number

14/096,414

Filing Date

12/04/2013

Included in

Biology Commons

Share

COinS